Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst Carey MacRury initiated coverage on Gold Royalty Corp. (AMEX:GROY) with a Buy rating and announced a price target of $3. Gold Royalty shares closed at $1.97 on Tuesday. See how other analysts view this stock.
- Jefferies analyst Dennis Ding initiated coverage on Mineralys Therapeutics, Inc. (NASDAQ:MLYS) …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst Carey MacRury initiated coverage on Gold Royalty Corp. (AMEX:GROY) with a Buy rating and announced a price target of $3. Gold Royalty shares closed at $1.97 on Tuesday. See how other analysts view this stock.
- Jefferies analyst Dennis Ding initiated coverage on Mineralys Therapeutics, Inc. (NASDAQ:MLYS) …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Canaccord Genuity analyst Carey MacRury initiated coverage on Gold Royalty Corp. (AMEX:GROY) with a Buy rating and announced a price target of $3. Gold Royalty shares closed at $1.97 on Tuesday. See how other analysts view this stock.
Jefferies analyst Dennis Ding initiated coverage on Mineralys Therapeutics, Inc. (NASDAQ:MLYS) …Full story available on Benzinga.com Read MoreCNR, COIN, GROY, MLYS, News, SMMT, Top Initiations, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, CNR, VGG3163G1046, COIN, US21254S1078, SMMT, GROY, MLYS, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
